Royal Capital Wealth Management’s Organon & Co OGN Stock Holding History

Royal Capital Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,942	Closed	-$267K	–	95
2024 Q3	$267K	Sell	13,942 -465	-3%	-$9.64K	0.19%	71
2024 Q2	$298K	Buy	14,407 +34	+0.2%	+$676	0.22%	64
2024 Q1	$270K	Buy	14,373 +3,038	+27%	+$52.1K	0.21%	71
2023 Q4	$163K	Buy	+11,335	New	+$154K	0.14%	90
2023 Q1	–	Sell	-7,975	Closed	-$223K	–	101
2022 Q4	$223K	Buy	+7,975	New	+$204K	0.24%	85
2022 Q3	–	Sell	-7,319	Closed	-$247K	–	97
2022 Q2	$247K	Buy	+7,319	New	+$256K	0.27%	77

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Capital Wealth Management's OGN Position: Q4 2024 in Review

Royal Capital Wealth Management sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 13,942 shares — an estimated $267K sold.

Royal Capital Wealth Management first reported a position in OGN in Q2 2022 and held it in 6 quarters. The position peaked at $298K in Q2 2024. 739 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

Royal Capital Wealth Management reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
Royal Capital Wealth Management sold 13,942 Organon & Co shares in Q4 2024, an estimated $267K.
Royal Capital Wealth Management first reported a position in Organon & Co in Q2 2022 and held it in 6 quarters.
Royal Capital Wealth Management's Organon & Co position peaked at $298K in Q2 2024.
739 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Royal Capital Wealth Management's 13F filing for Q4 2024, filed 18 Feb 2025.